Celyad Oncology Announces March 2021 Conference Schedule
Regulatory News:
Celyad Oncology SA (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD) (Euronext Nasdaq: CYAD), a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer, today announced that the company plans to participate at the following virtual investor conferences in March 2021:
H.C. Wainwright Global Life Sciences Conference
Date: Tuesday, March 9 Wednesday, March 10, 2021
Time: 7:00 a.m. ET 1:00 p.m. CET
Webcast: A webcast of the presentation will be available in the Events section of the Celyad Oncology website for approximately 90 days from the start of the event
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
uniQure to Participate in Multiple Upcoming Industry Conferences in March
uniQure Inc.February 26, 2021 GMT
LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Feb. 26, 2021 (GLOBE NEWSWIRE) uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced its participation in the following upcoming virtual investor and scientific conferences: Cowen 41st Annual Health Care Conference, March 1 - 4, 2021 Members of uniQure’s management team including Matt Kapusta, chief executive officer, and Ricardo Dolmetsch, Ph.D., president of research & development, will participate in virtual one-on-one investor meetings throughout the day on Monday, March 1.
Mid-Day Market Update: Nasdaq Rises Over 100 Points; Recro Pharma Shares Plummet benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
LogicBio Therapeutics to Present at Upcoming Investor Conferences
News provided by
Share this article
Share this article
LEXINGTON, Mass., Feb. 26, 2021 /PRNewswire/ LogicBio Therapeutics, Inc. (Nasdaq:LOGC), a clinical-stage genetic medicine company pioneering gene delivery and gene editing platforms to address rare and serious diseases from infancy through adulthood, today announced that chief executive officer Frederic Chereau will be presenting an overview of the company at upcoming investor conferences.
Mr. Chereau will present at the Barclays Global Healthcare Conference on Thursday, March 11, 2021 at 4:10 p.m. ET. A link to the Barclays presentation will be available under the Events and Presentations section of LogicBio s website, found here: https://investor.logicbio.com/events-and-presentations/events.
uniQure Inc : uniQure to Participate in Multiple Upcoming Industry Conferences in March finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.